Bosnjak Zeljko J, Yan Yasheng, Canfield Scott, Muravyeva Maria Y, Kikuchi Chika, Wells Clive W, Corbett John A, Bai Xiaowen
Department of Anesthesiology, The Medical College of Wisconsin, Milwaukee, 53226, USA.
Curr Drug Saf. 2012 Apr;7(2):106-19. doi: 10.2174/157488612802715663.
Ketamine is widely used for anesthesia in pediatric patients. Growing evidence indicates that ketamine causes neurotoxicity in a variety of developing animal models. Our understanding of anesthesia neurotoxicity in humans is currently limited by difficulties in obtaining neurons and performing developmental toxicity studies in fetal and pediatric populations. It may be possible to overcome these challenges by obtaining neurons from human embryonic stem cells (hESCs) in vitro. hESCs are able to replicate indefinitely and differentiate into every cell type. In this study, we investigated the toxic effect of ketamine on neurons differentiated from hESCs. Two-week-old neurons were treated with different doses and durations of ketamine with or without the reactive oxygen species (ROS) scavenger, Trolox. Cell viability, ultrastructure, mitochondrial membrane potential (ΔΨm), cytochrome c distribution within cells, apoptosis, and ROS production were evaluated. Here we show that ketamine induced ultrastructural abnormalities and dose- and time-dependently caused cell death. In addition, ketamine decreased ΔΨm and increased cytochrome c release from mitochondria. Ketamine also increased ROS production and induced differential expression of oxidative stress-related genes. Specifically, abnormal ultrastructural and ΔΨm changes occurred earlier than cell death in the ketamine-induced toxicity process. Furthermore, Trolox significantly decreased ROS generation and attenuated cell death caused by ketamine in a dose-dependent manner. In conclusion, this study illustrates that ketamine time- and dose-dependently induces human neurotoxicity at supraclinical concentrations via ROS-mediated mitochondrial apoptosis pathway and that these side effects can be prevented by the antioxidant agent Trolox. Thus, hESC-derived neurons might provide a promising tool for studying anesthetic-induced developmental neurotoxicity and prevention strategies.
氯胺酮广泛用于儿科患者的麻醉。越来越多的证据表明,氯胺酮在多种发育中的动物模型中会导致神经毒性。目前,我们对人类麻醉神经毒性的理解受到获取神经元以及在胎儿和儿科人群中进行发育毒性研究困难的限制。通过在体外从人类胚胎干细胞(hESC)中获取神经元,有可能克服这些挑战。hESC能够无限复制并分化为每种细胞类型。在本研究中,我们研究了氯胺酮对从hESC分化而来的神经元的毒性作用。用不同剂量和持续时间的氯胺酮处理两周大的神经元,同时加入或不加入活性氧(ROS)清除剂托可索仑(Trolox)。评估细胞活力、超微结构、线粒体膜电位(ΔΨm)、细胞色素c在细胞内的分布、细胞凋亡和ROS产生。我们在此表明,氯胺酮诱导超微结构异常,并剂量和时间依赖性地导致细胞死亡。此外,氯胺酮降低了ΔΨm,并增加了细胞色素c从线粒体的释放。氯胺酮还增加了ROS的产生,并诱导了氧化应激相关基因的差异表达。具体而言,在氯胺酮诱导的毒性过程中,异常的超微结构和ΔΨm变化比细胞死亡出现得更早。此外,托可索仑显著降低了ROS的产生,并以剂量依赖性方式减轻了氯胺酮引起的细胞死亡。总之,本研究表明,氯胺酮在超临床浓度下通过ROS介导线粒体凋亡途径时间和剂量依赖性地诱导人类神经毒性,并且这些副作用可以通过抗氧化剂托可索仑预防。因此,hESC来源的神经元可能为研究麻醉诱导的发育性神经毒性和预防策略提供一个有前景的工具。